SCHEMBL13636947

SCHEMBL13636947

CC(=N)c1csc(-c2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 3/20 0.41
HSD17B1 P14061 8/20 0.41
HSD17B2 P37059 8/20 0.41
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
CHRNA7 P36544 1/20 0.40
HTR3A P46098 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 1/20 0.39
AR P10275 1/20 0.38
CNR1 P21554 1/20 0.38
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14395937 0.82 MAPT (0.40) HSD17B1HSD17B2CYP3A4CYP2C9CNR1
SCHEMBL19453513 0.81 PRSS1 (0.43) NQO2HSD17B1HSD17B2HTR3EHTR3B
SCHEMBL10367391 0.81 MAPT (0.52) NQO2HSD17B1HSD17B2HTR3EHTR3B
SCHEMBL11400156 0.77 HSD17B1 (0.43) NQO2HSD17B1HSD17B2HTR3EHTR3B
SCHEMBL938500 0.77 KMO (0.52) HSD17B1HSD17B2HTR3EHTR3BCHRNA7
SCHEMBL27605120 0.77 HSD17B1 (0.52) HSD17B1HSD17B2HTR3EHTR3BCHRNA7
SCHEMBL10367856 0.74 ATM (0.55) HSD17B1HSD17B2HTR3EHTR3BCHRNA7
SCHEMBL6666581 0.74 IKBKB (0.53) NQO2HSD17B1HSD17B2HTR3EHTR3B
SCHEMBL725065 0.74 RAB9A (0.53) HSD17B1HSD17B2HTR3EHTR3BCHRNA7
SCHEMBL2454052 0.74 TSHR (0.53) HSD17B1HSD17B2HTR3EHTR3BCHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606255-B1 CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL MYERS SQUIBB CO (US) 2009-11-11 EP disclosed